BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21233067)

  • 21. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
    Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
    Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
    [No Abstract]   [Full Text] [Related]  

  • 22. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.
    Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM
    Br J Haematol; 2012 Jan; 156(1):142-3. PubMed ID: 21848889
    [No Abstract]   [Full Text] [Related]  

  • 23. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
    Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
    Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHOP plus rituximab--balancing facts and opinion.
    Cheson BD
    N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154
    [No Abstract]   [Full Text] [Related]  

  • 25. Diffuse large B-cell lymphoma resembling a metastatic liver tumour.
    Saitoh Y; Gotoh M; Katagiri S; Ohyashiki K
    Br J Haematol; 2015 Jan; 168(1):1. PubMed ID: 25312576
    [No Abstract]   [Full Text] [Related]  

  • 26. Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy.
    Pantelaki I; Tigges C; Nußbaum T; Oellig F; Wieland U; Kreuter A
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508527
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
    Chen DB; Wang Y; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):635-6. PubMed ID: 21092597
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
    Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
    Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravascular Large B-Cell Lymphoma of the Gallbladder.
    Çetin B; Akyürek N; Metin Y; Karaca F; Bilgetekin İ; Özet A
    Turk J Haematol; 2018 May; 35(2):145-146. PubMed ID: 29391332
    [No Abstract]   [Full Text] [Related]  

  • 30. Macrophage colony-stimulating factor produced by diffuse large B-cell lymphoma.
    Nakayama-Ichiyama S; Yokote T; Oka S; Takubo T; Tsuji M; Hanafusa T
    Br J Haematol; 2010 May; 149(3):310. PubMed ID: 20085576
    [No Abstract]   [Full Text] [Related]  

  • 31. [A case report of composite lymphoma].
    Wu J; Wang ZC; Chen XD
    Ai Zheng; 2007 Apr; 26(4):447. PubMed ID: 17430672
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
    Furman RR; Martin P; Ruan J; Cheung YK; Vose JM; LaCasce AS; Elstrom R; Coleman M; Leonard JP
    Cancer; 2010 Dec; 116(23):5432-9. PubMed ID: 20665890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary diffuse large B-Cell lymphoma of the prostate presenting with urinary retention and dyschezia for which rituximab-combined CHOP therapy was effective-a case presentation.
    Manabe M; Hayashi Y; Yoshii Y; Mukai S; Sakamoto E; Kanashima H; Nakao T; Hayama T; Fukushima H; Inoue T; Yamane T; Teshima H
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1733-5. PubMed ID: 23152030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
    N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjunctival lymphoma in a child.
    Waisbourd M; Leibovitch I; Sayar D; Elhasid R
    Cornea; 2011 May; 30(5):598-9. PubMed ID: 21107252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-CD20 antibody therapy for B-cell lymphomas.
    Maloney DG
    N Engl J Med; 2012 May; 366(21):2008-16. PubMed ID: 22621628
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of diffuse large B-cell lymphoma].
    Gleissner B; Zwick C; Pfreundschuh M
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1785-94; quiz 1795-6. PubMed ID: 18767006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
    Copson E
    Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
    Hosoi M; Yamamoto G; Imai Y; Kurokawa M
    Ann Hematol; 2010 Feb; 89(2):207-8. PubMed ID: 19582454
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical analysis of primary gastric diffuse large B-cell lymphoma].
    Zhang J; Wang MY; Xu LC; Gu SY; Cao JN; Hu XC; Hong XN
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):614-8. PubMed ID: 21122416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.